AXSM
Axsome Therapeutics Inc
NASDAQ: AXSM · HEALTHCARE · BIOTECHNOLOGY
$207.75
+12.94% today
Updated 2026-04-30
Market cap
$9.46B
P/E ratio
—
P/S ratio
14.82x
EPS (TTM)
$-3.68
Dividend yield
—
52W range
$96 – $193
Volume
0.7M
Axsome Therapeutics Inc (AXSM) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.10M | $2.79M | $49.08M | $38.21M | $35.56M | $15.38M | $220.55M | $186.13M | $87.79M | $331.48M | $588.24M | $568.50M |
| Cash & equivalents | $2.09M | $2.62M | $48.04M | $36.62M | $34.02M | $13.97M | $219.97M | $183.88M | $86.47M | $200.84M | $386.19M | $315.35M |
| Current assets | $2.10M | $2.74M | $49.03M | $38.00M | $35.30M | $15.22M | $220.38M | $184.02M | $86.52M | $245.64M | $504.26M | $485.06M |
| Total liabilities | $4.13M | $5.99M | $2.63M | $16.64M | $18.84M | $14.44M | $41.83M | $72.34M | $72.15M | $221.92M | $397.26M | $511.48M |
| Current liabilities | $4.13M | $972616.00 | $2.63M | $7.17M | $12.18M | $10.82M | $24.49M | $23.44M | $23.07M | $96.56M | $138.85M | $230.10M |
| Long-term debt | — | $4.44M | — | $9.47M | $6.66M | $3.62M | $17.33M | $48.32M | $49.09M | $94.26M | $178.07M | $180.71M |
| Shareholder equity | $-2.03M | $-3.20M | $46.44M | $21.57M | $16.72M | $937921.00 | $-175.90M | $113.79M | $15.63M | $109.56M | $190.98M | $57.02M |
| Retained earnings | $-2.23M | $-8.23M | $-20.44M | $-47.64M | $-76.58M | $-107.55M | $-175.90M | $-278.80M | $-409.20M | $-596.33M | $-835.57M | $-1.12B |
| Accounts receivable | — | — | — | — | — | — | — | — | $0.00 | $37.70M | $94.82M | $142.00M |
| Inventory | — | — | — | $0.00 | $0.00 | — | — | — | $0.00 | $4.32M | $15.13M | $15.73M |
| Goodwill | — | — | — | $0.00 | $0.00 | — | — | — | $0.00 | $10.31M | $12.04M | $12.04M |